HSCSW | Heart Test Laboratories, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0338 - 0.0499
52 Week Range	0.0338 - 0.0499
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	200
Average Volume	N/A
Shares Outstanding	76,470,355
Market Cap	2,650,081
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2022-06-15

Valuation
Profitability
Growth
Health
P/E Ratio	-0.03
Forward P/E Ratio	N/A
EPS	-1.09
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	15
Country	USA
Website	HSCSW

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

HSCSW's peers: NXLIW

*Chart delayed

Analyzing fundamentals for HSCSW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see HSCSW Fundamentals page.

Watching at HSCSW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on HSCSW Technicals page.